药品注册申请号:062702
申请类型:ANDA (仿制药申请)
申请人:TEVA
申请人全名:TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE No No AB 1987/02/13 1987/02/13 Prescription
002 CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE No No AB 1987/02/13 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2012/08/21 SUPPL-60(补充) Approval Labeling STANDARD
2011/02/22 SUPPL-58(补充) Approval Labeling
2009/11/16 SUPPL-56(补充) Approval Labeling
2007/09/27 SUPPL-54(补充) Approval Labeling
2007/02/08 SUPPL-52(补充) Approval Labeling
2003/11/13 SUPPL-49(补充) Approval Labeling
2003/09/22 SUPPL-48(补充) Approval Labeling
2002/07/31 SUPPL-45(补充) Approval Manufacturing (CMC)
2002/06/18 SUPPL-43(补充) Approval Manufacturing (CMC)
2002/05/20 SUPPL-44(补充) Approval Manufacturing (CMC)
2001/10/24 SUPPL-42(补充) Approval Manufacturing (CMC)
2001/08/14 SUPPL-41(补充) Approval Manufacturing (CMC)
2000/07/07 SUPPL-40(补充) Approval Manufacturing (CMC)
1999/12/20 SUPPL-39(补充) Approval Manufacturing (CMC)
1998/07/29 SUPPL-38(补充) Approval Manufacturing (CMC)
1997/12/10 SUPPL-37(补充) Approval Manufacturing (CMC)
1997/05/02 SUPPL-36(补充) Approval Manufacturing (CMC)
1997/02/07 SUPPL-35(补充) Approval Labeling
1997/01/10 SUPPL-34(补充) Approval Manufacturing (CMC)
1997/01/03 SUPPL-33(补充) Approval Manufacturing (CMC)
1996/06/03 SUPPL-32(补充) Approval Manufacturing (CMC)
1995/07/14 SUPPL-29(补充) Approval Manufacturing (CMC)
1995/02/16 SUPPL-31(补充) Approval Manufacturing (CMC)
1994/09/06 SUPPL-30(补充) Approval Manufacturing (CMC)
1993/10/13 SUPPL-28(补充) Approval Labeling
1993/10/13 SUPPL-27(补充) Approval Labeling
1992/10/13 SUPPL-26(补充) Approval Labeling
1992/10/13 SUPPL-25(补充) Approval Manufacturing (CMC)
1992/08/10 SUPPL-24(补充) Approval Labeling
1989/03/20 SUPPL-23(补充) Approval Manufacturing (CMC)
1988/10/27 SUPPL-22(补充) Approval Manufacturing (CMC)
1988/10/27 SUPPL-20(补充) Approval Manufacturing (CMC)
1987/02/13 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CEPHALEXIN 剂型/给药途径:CAPSULE;ORAL 规格:EQ 250MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
062702 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 1987/02/13 TEVA
062713 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 1988/07/15 BELCHER PHARMS
065152 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 2005/02/24 CHARTWELL RX
065248 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 2005/06/28 ANDA REPOSITORY
065253 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 2005/11/16 AUROBINDO PHARMA
065229 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 2005/11/25 LUPIN
065215 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Discontinued No No AB 2006/01/24 HIKMA
090836 001 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 250MG BASE Prescription No No AB 2010/12/20 ALKEM LABS LTD
活性成分:CEPHALEXIN 剂型/给药途径:CAPSULE;ORAL 规格:EQ 500MG BASE 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
062702 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 1987/02/13 TEVA
062713 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 1988/07/15 BELCHER PHARMS
065152 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 2005/02/24 CHARTWELL RX
065248 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 2005/06/28 ANDA REPOSITORY
065253 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 2005/11/16 AUROBINDO PHARMA
065229 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 2005/11/25 LUPIN
065215 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Discontinued No No AB 2006/01/24 HIKMA
090836 002 ANDA CEPHALEXIN CEPHALEXIN CAPSULE;ORAL EQ 500MG BASE Prescription No No AB 2010/12/20 ALKEM LABS LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database